Navigation Links
Luminex Corporation Second Quarter Earnings Release Scheduled for August 3, 2015
Date:7/13/2015

AUSTIN, Texas, July 13, 2015 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter ended June 30, 2015 on Monday, August 3, 2015. A press release announcing the results is scheduled for release after the close of trading.

Management will hold a conference call to discuss the operating highlights and financial results for the second quarter ended June 30, 2015 on August 3, 2015, at 4:30 p.m. Eastern time.

The conference call will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the website, go to the About Us section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the call to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the call will be archived for six months on the website using the 'replay' link.

The use of pop-up blocking software may impair your ability to view webcasts. If you use this software, press and hold the CTRL key when you click on the Register button. Please contact your IT group if you are unable to override this feature. Unauthorized recording or downloading of this event is not permitted.

About Luminex Corporation

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.

Luminex Corporate Contact:
Harriss Currie, 512.219.8020
Sr. Vice President, Finance and CFO
hcurrie@luminexcorp.com

Luminex Investor Contact:
Matthew Scalo, 512.219.8020
Sr. Director, Investor Relations
mscalo@luminexcorp.com

Logo - http://photos.prnewswire.com/prnh/20150201/172702LOGO

 


'/>"/>
SOURCE Luminex Corporation
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
2. Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporations xMAP Technology
3. Luminex Corporation Second Quarter Earnings Release Scheduled for July 29, 2013
4. Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
5. Luminex Corporation Reports Second Quarter 2013 Results
6. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
7. LUMINEX CORPORATION TO HOST INVESTOR EVENT AT ASSOCIATION FOR MOLECULAR PATHOLOGY ANNUAL MEETING
8. Luminex Corporation Reports Third Quarter 2013 Results
9. Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
10. Luminex Corporation Reports Second Quarter 2014 results
11. Luminex Is Supporting U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Research Efforts to Control African Ebola Outbreak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2019)... , ... October 19, 2019 , ... Hospital M&A activity ... according to new acquisition data from HealthCareMandA.com. The most recent quarter was down 20% ... was up sharply compared with the second quarter, totaling nearly $5.0 billion, a 291% ...
(Date:10/17/2019)... ... October 17, 2019 , ... Women’s concern in the wake ... of textured implants is the subject of a September 24 article on ... says that the Allergan recall has revived a number of issues, including a possible ...
(Date:10/15/2019)... ... October 14, 2019 , ... ... calibration verification kit, for Roche cobas® analyzers, Order No. 507ro. The kit, ... Each VALIDATE® LP2 kit, liquid, ready-to-use, and prepared using the CLSI ...
Breaking Medicine Technology:
(Date:10/15/2019)... , ... October 14, 2019 , ... Khalieghya Dandie-Evans, a ... to ride atop the Donate Life Rose Parade® float in the 131st Rose Parade® ... and tissue donation across Northern California and Northern Nevada, the organization’s service area. , ...
(Date:10/15/2019)... , ... October 15, 2019 , ... Nashville Fertility Center ... the latest fertility doctor to join the practice. In addition to treating general infertility, ... (PCOS). , The team at NFC looks forward to Dr. Van Heertum joining the ...
(Date:10/10/2019)... ... October 10, 2019 , ... Santa Rosa ... services for the healthcare industry, has completed the first phase of a comprehensive ... Commonwealth of The Bahamas towards a fully integrated health information management system (iHIMS). ...
(Date:10/8/2019)... ... October 08, 2019 , ... SoCal Adolescent Wellness announces ... to announce the expansion of our services to better serve the families in Orange ... this last year to see the extraordinary impact this pre-intervention program has on the ...
(Date:10/8/2019)... ... October 08, 2019 , ... As a world-renowned expert using ... professor with the University of Maryland Department of Veterinary Medicine, continues to make ... Shi and his lab have discovered a new pathway by which liver macrophages ...
Breaking Medicine News(10 mins):